FUSION CONSTRUCTS CONTAINING ACTIVE SECTIONS OF TNF LIGANDS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14521631

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is a recombinant fusion protein containing an amino-acid sequence which comprises: (a) the Fc section or part of an Fc section of an immunoglobulin as component (A) or a functional variant of component (A); (b) the extracellular part of a TNF ligand or a partial sequence of the extracellular part of a TNF ligand as component (B) or a functional variant of component (B); and optionally (c) a transition area between component (A) and component (B), containing a linker.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONXEOPARIS FRA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gaide, Olivier Geneva, CH 5 29
Schneider, Pascal Epalinges, CH 40 334
Tschopp, Jurg Epalinges, CH 39 316

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation